[Retracted] Correlation between the Variability of Glycosylated Hemoglobin and Cardiovascular Risk in New-Onset T2DM Patients

Table 2

Comparison of clinical data of patients with different HGI levels.

Clinical data	Low HGI (n = 37)	Medium HGI (n = 38)	High HGI (n = 37)	F/χ^2	value
Gender				0.488	0.784
Male	21	20	18
Female	16	18	19
Average age (years)	60.24 ± 10.91	61.35 ± 11.23	60.78 ± 9.57	0.103	0.902
BMI (kg/m^2)	22.89 ± 2.11	23.12 ± 2.85	22.56 ± 2.63	0.455	0.635
Drinking history n (%)	11	13	12	0.175	0.916
Smoking history n (%)	10	9	8	0.301	0.86
Hypertension n (%)	13	18	19	2.141	0.343
Hyperlipidemia n (%)	5	7	7	0.47	0.79
Drug treatment n (%)				13.039	0.001
Diabetes	31	28	17
Insulin	6	10	20
Laboratory index
FPG (mmol/L)	7.12 ± 1.31	8.23 ± 1.47	9.55 ± 1.29	29.601	0
TC (mmol/L)	5.12 ± 0.98	5.43 ± 1.02	5.98 ± 1.14	6.386	0.002
TG (mmol/L)	2.09 ± 0.36	2.10 ± 0.28	2.14 ± 0.43	0.199	0.82
LDL-C (mmol/L)	3.18 ± 0.76	3.22 ± 0.81	3.25 ± 0.79	0.074	0.929
HDL-C (mmol/L)	1.31 ± 0.32	1.26 ± 0.29	1.27 ± 0.30	0.283	0.754
SUA (μmol/L)	366.37 ± 121.45	370.18 ± 109.74	375.23 ± 103.46	0.059	0.943
HbA1c (%)	6.41 ± 1.05	7.23 ± 1.23	9.40 ± 1.58	51.943	0
CVD n (%)	1	4	19	30.065	0